Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by n-Lorem Foundation

n-Lorem Foundation Identifies New, Important Roles of JIP3, Offering Critical Insights into Therapeutic Approaches for Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Celebrates Five Years of Bringing Hope and Potential Treatments to Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation’s Nano-rare Patient Colloquium Draws More Than 750 attendees, Reinforcing Need for Treatment Options for People with Nano-rare Illnesses
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Has Treated 15 Nano-rare Patients and Expects to Treat More Than 25 Nano-rare Patients by Year End
From n-Lorem Foundation
Via Business Wire
n-Lorem Publishes Recommendations for Treating Patients with Heterozygous Toxic Gain of Function Mutations
From n-Lorem Foundation
Via Business Wire
Positive Clinical Observations from n-Lorem Treated, KIF1A Nano-rare Patient Published in Nature Medicine
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Names Andrew W. Lo as a New Member of its Board of Directors
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Welcomes New Member Alan Lotvin to Its Board of Directors
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Announces the Second Annual Nano-rare Patient Colloquium Will be Held on Oct. 30 & 31, 2024
From n-Lorem Foundation
Via Business Wire
n-Lorem Provides Update on Its Remarkable Progress to Deliver Hope and Potential Help to More Than 100 Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Unveils Limited Edition Holiday Ornament to Support its Mission to Provide Optimized ASO Therapies to Nano-rare Patients For Free, For Life
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Founder and CEO, Stanley Crooke, Named One of San Diego’s Most Influential People by the San Diego Business Journal
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Convenes First Annual Nano-rare Patient Colloquium to Share Accomplishments and Learnings in Developing Optimized ASO Therapies for Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Collaborates to Support Children With Extremely Rare Diseases
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Founder and CEO, Stanley Crooke, M.D., Ph.D., Awarded the Steven C. Beering Award
From n-Lorem Foundation
Via Business Wire
n-Lorem Has Industrialized the Treatment of Nano-rare Patients and Formed Key Committees
From n-Lorem Foundation
Via Business Wire
n-Lorem Publishes Paper Defining Needed Health Care Reforms to Provide an Integrated Holistic Approach for Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem’s Patient Empowerment Program Approaches One Year Mark With More Than 5000 Episode Downloads
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Awarded Prestigious 2023 Edison Award
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Begins 2023 with More Than 80 Active Patient Programs
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Welcomes New Members, Paul Compton and Neil Shneider, to its Board of Directors
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Launches New Website to Support its Nano-rare Patients, Treating Physicians and Institutions
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Initiates Clinical Trials for Three Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation CEO, Stanley Crooke, M.D., Ph.D., Chosen as 2022 Roy Vagelos Pro Bono Humanum Award for Global Health Equity of the Prix Galien
From n-Lorem Foundation
Via Business Wire
SOLVE FSHD Provides Funding to n-Lorem for a Collaboration to Expand Understanding of FSHD2, a Rare Form of Muscular Dystrophy
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation and Ultragenyx United in Efforts to Help Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation Introduces First ‘Partner in Excellence’ to Support and Accelerate the Treatment of Nano-rare Patients
From n-Lorem Foundation
Via Business Wire
n-Lorem Launches its Patient Empowerment Program to Support Nano-rare Patients and Their Families
From n-Lorem Foundation
Via Business Wire
n-Lorem Foundation and Columbia University Establish Silence ALS Initiative
From n-Lorem Foundation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.